NewSplash Archive – March 2018
FDA approves world’s smallest mechanical heart valve
The U.S. Food and Drug Administration (FDA) approved the Masters HP 15 mm rotatable mechanical heart valve. The dime-sized valve is the world’s smallest mechanical heart valve and will allow doctors to treat infants and toddlers who need a mitral or aortic valve replacement.
IBM develops superbug-killing molecule
Antibiotic-resistant bacteria is a global problem and there are few new antibiotics on the horizon. Scientists at IBM’s Almaden Research Laboratory have taken a novel approach to the growing crisis and designed a new molecule, called a polymer, that targets and kills five deadly types of drug-resistant microbes.
Researchers develop lens-free fluorescent microscope
Engineers at Rice University have developed FlatScope, a thin fluorescent microscope that can be used as an implantable endoscope, a large-area imager, or a flexible microscope. The lens-free FlatScope is a wide-field microscope that’s thinner than a credit card, small enough to sit on a fingertip, and capable of micrometer resolution over a volume of several cubic millimeters.
The Front Line
NewSplash is proud to present The Front Line, a feature column by Hank Balch. Each article is devoted to objectives and perspectives to help sterile processing professionals keep patients safe. This exclusive biweekly column will begin April 3 in Volume 2, Issue 14.
3D printing custom spinal implants
Researchers at the University College London have recently designed and fabricated anatomically shaped spinal implants using 3D printing. By closely collaborating with clinicians, researchers have realistic computational models that take into account patient factors, such as the type and severity of spinal disease.
Artificial photoreceptors restore vision to blind mice
A team of researchers from Fudan University in China has developed a way of replacing photoreceptors in blind mice with gold/titanium oxide nanowire arrays, which function much like the diseased rod and cone cells they replace. The artificial photoreceptors are implanted into the eye and convert light into electrical signals, passing the generated electricity to existing retinal cells.
New Beyond Clean episode is now available
This week’s guest on Beyond Clean is Robert Edelstein, president of Millennium Surgical Corp., a division of Avalign Technologies. Millennium Surgical has developed and refined a business model focused on expert support, high-quality U.S.- and German-made specialty surgical instruments, and systems that enable hospitals and surgical centers to quickly locate and compare most specialty surgical instruments.
Stanford researchers develop stretchable, touch-sensitive electronics
In a major step forward in the creation of artificial skin, researchers at Stanford have created stretchable circuitry that can feel the touch of a ladybug. The material is a stretchable polymer with integrated touch sensors.
Light-activated gold nanoparticles deliver targeted, noninvasive drugs
Doctoral candidate Alona Shagan and Assistant Professor Boaz Mizrahi have developed a technology that enables drugs to be delivered and released only to the diseased tissue which the drug is targeting. The new method uses a unique polymer coating that contains nanoscale gold particles, in addition to the drug itself.
APIC 2018 Online Program Planner is live
Are you attending APIC 2018? To help you get the most out of the conference, APIC has released the 2018 Online Program Planner. The program allows you to search and view all of the education sessions by date, session type, track, title, session number, speakers, career stage, and keyword.
Pure-Vu colon cleansing system received CE Mark
Motus GI received the European CE Mark of approval for the Pure-Vu System, which integrates with standard colonoscopes to enable cleaning of a poorly prepped colon during the procedure, while preserving standard procedural workflow techniques. The Pure-Vu System fits over most standard colonoscopes and uses a mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, providing a clear view of areas that are obstructed due to poor prep.
PROCEPT BioRobotics raises $118m for aquablation prostate treatment
U.S. surgical robotics firm PROCEPT BioRobotics has raised $118 million in funding for the worldwide commercialization of its AquaBeam aquablation system for the minimally invasive treatment of benign prostatic hyperplasia (BPH). BPH is a highly prevalent condition that affects around 50% of men age 60 or older, and 90% of men age 85 or older.
New Beyond Clean episode is now available
This week’s guests on Beyond Clean are Brian Reynolds and Tony Thurmond, the two IAHCSMM president-elect candidates for 2018. Brian is the assistant chief SPS at the Birmingham VA Medical Center, and Tony is the CS manager at The Christ Hospital Health Network.